Advocacy intelligence hub — real-time data for patient organizations
University of California, San Francisco — PHASE1, PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Progressive encephalomyelitis with rigidity and myoclonus news →
View all Progressive encephalomyelitis with rigidity and myoclonus specialists →